Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B K Madras

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Annals of Neurology|March 1, 1994
11C-WIN 35,428 for detecting dopamine depletion in mild Parkinson's diseaseB K Madras
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeysM Goulet, B K Madras
Molecular Psychiatry|October 17, 1998
Anti-hyperactivity medication: methylphenidate and amphetamineP Seeman, B K Madras
Advances in Biochemical Psychopharmacology|January 1, 1983
Modulation of dopamine receptor binding by ascorbic acidB K Madras, B Chan
European Journal of Pharmacology|March 4, 1983
Partial purification of [3H]mianserin binding sitesB Chan, B K Madras
European Journal of Pharmacology|September 10, 1982
[3H]Mianserin binding to solubilized membranes of frontal cortexB Chan, B K Madras
Handbook of Experimental Pharmacology|May 26, 2006
Human genetics and pharmacology of neurotransmitter transportersZ Lin, B K Madras
Journal of Neurochemistry|March 1, 1985
Drug potencies on partially purified brain D2 dopamine receptorsB K Madras, P Seeman
Molecular Psychiatry|January 23, 2002
Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expressionG M Miller, B K Madras
Synapse (New York, N.Y.)|September 1, 1991
Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatumM J Kaufman, B K Madras
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Annals of Neurology|March 1, 1994
11C-WIN 35,428 for detecting dopamine depletion in mild Parkinson's diseaseB K Madras
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeysM Goulet, B K Madras
Molecular Psychiatry|October 17, 1998
Anti-hyperactivity medication: methylphenidate and amphetamineP Seeman, B K Madras
Advances in Biochemical Psychopharmacology|January 1, 1983
Modulation of dopamine receptor binding by ascorbic acidB K Madras, B Chan
European Journal of Pharmacology|March 4, 1983
Partial purification of [3H]mianserin binding sitesB Chan, B K Madras
European Journal of Pharmacology|September 10, 1982
[3H]Mianserin binding to solubilized membranes of frontal cortexB Chan, B K Madras
Handbook of Experimental Pharmacology|May 26, 2006
Human genetics and pharmacology of neurotransmitter transportersZ Lin, B K Madras
Journal of Neurochemistry|March 1, 1985
Drug potencies on partially purified brain D2 dopamine receptorsB K Madras, P Seeman
Molecular Psychiatry|January 23, 2002
Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expressionG M Miller, B K Madras
Synapse (New York, N.Y.)|September 1, 1991
Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatumM J Kaufman, B K Madras
Pageof 9